Whilst Prime Minister Rishi Sunak and Labour party leader Keir Starmer, centre attention on migration and tax policies, the UK healthcare industry awaits a new government that will tackle Brexit’s effects on the life sciences sector and a labyrinthine regulatory process.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,